Programmed death-1 pathway blockade produces a synergistic antitumor effect: combined application in ovarian cancer.
about
Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review.Janus-Faced Myeloid-Derived Suppressor Cell Exosomes for the Good and the Bad in Cancer and Autoimmune Disease.Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand- 1 (PD-L1) in ovarian cancer.Targeted therapy and immunotherapy for platinum-refractory advanced ovarian adenosquamous carcinoma: a case report.Sperm Protein 17 Expression by Murine Epithelial Ovarian Cancer Cells and Its Impact on Tumor ProgressionSoluble PD-1 ligands regulate T-cell function in Waldenstrom macroglobulinemia
P2860
Programmed death-1 pathway blockade produces a synergistic antitumor effect: combined application in ovarian cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Programmed death-1 pathway blo ...... application in ovarian cancer.
@en
Programmed death-1 pathway blo ...... application in ovarian cancer.
@nl
type
label
Programmed death-1 pathway blo ...... application in ovarian cancer.
@en
Programmed death-1 pathway blo ...... application in ovarian cancer.
@nl
prefLabel
Programmed death-1 pathway blo ...... application in ovarian cancer.
@en
Programmed death-1 pathway blo ...... application in ovarian cancer.
@nl
P2860
P921
P356
P1476
Programmed death-1 pathway blo ...... application in ovarian cancer
@en
P2093
Jinghe Lang
Xinxin Zhu
P2860
P356
10.3802/JGO.2017.28.E64
P5008
P577
2017-06-05T00:00:00Z
2017-09-01T00:00:00Z